ZICLUMERAN EXPRESSED CRISPR-ASSOCIATED PROTEIN 9
UNII HB8LE6H4UK

Substance Identification & Data

This profile provides standardized clinical and technical data for Ziclumeran Expressed Crispr-associated Protein 9, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HB8LE6H4UK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
HB8LE6H4UK
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ZICLUMERAN EXPRESSED CRISPR-ASSOCIATED PROTEIN 9
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ziclumeran Expressed Crispr-associated Protein 9. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ZICLUMERAN CAS9 EXPRESSED PROTEIN
ZICLUMERAN EXPRESSED CRISPR-ASSOCIATED PROTEIN 9

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record